Awareness of and compliance with recommended dietary supplement among age-related macular degeneration patients

Clinical and Experimental Ophthalmology

Volumn 34, Issue 1, 2006, Pages 9-14

  Ng, W T Weng T ^a,b   Goggin, Michael ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Age Related Eye Disease Study supplement; Age related macular degeneration; Awareness; Compliance; Public health

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; COPPER; ZINC;

ADULT; AGED; ARTICLE; AUSTRALIA; AWARENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG COST; DRUG DOSE REGIMEN; DRUG POTENTIATION; EYE FUNDUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREDICTION; PREVALENCE; PUBLIC HEALTH; RETINA MACULA AGE RELATED DEGENERATION; SMOKING; TEACHING HOSPITAL; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NUTRITIONAL REQUIREMENTS; PATIENT COMPLIANCE; PUBLIC HEALTH; VITAMINS; ZINC;

EID: 33644886337     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01141.x     Document Type: Article

References (25)

1. Attebo K, Mitchell P, Smith W. Visual acuity and the cause of visual loss in Australia: The Blue Mountains Eye Study. Ophthalmology 1996; 103: 357-64.
2. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, deJong PT. Age-specific prevalence and cause of blindness and visual impairment in an older population: The Rotterdam Study. Arch Ophthalmol 1998; 116: 653-8.
3. National Advisory Eye Council. Report of the Retinal Diseases Panel: Vision Research: A National Plan, 1994-1998. Bethesda, MD: United States Department of Human Services, 1993; Publication NIH 93-3186.
4. Klein R, Wang Q, Klein BEK, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995; 36: 182-91.
5. Bressler NM. Age-related macular degeneration. New hope for a common problem comes from photodynamic therapy. Br Med J 2000; 321: 1425-7.
6. Newsome DA, Swartz M, Leone NC, Elston RC, Miller E. Oral zinc in macular degeneration. Arch Ophthalmol 1988; 106: 192-8.
7. Kaiser HJ, Flammer J, Stumpig D, Hendrickson P. Visaline in the treatment of age-related macular degeneration - a pilot study. Ophthalmologica 1995; 209: 302-5.
8. Stur M, Tittl M, Reitner A, Meisinger V. Oral zinc and second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 1996; 37: 1225-35.
9. Teikari JM, Laatikainen L, Virtamo J et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 1998; 76: 224-9.
10. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and visual loss: AREDS Report No. 8. Arch Ophthalmol 2001; 119: 1417-36.
11. Taylor HR, Tikellis G, Robman LD, McCarthy CA, McNeil JJ. Vitamin E supplementation and macular degeneration: Randomized controlled trial. Br Med J 2002; 325: 1-4.
12. Richer S, Stiles W, Statkute L et al. The lutein antioxidant supplementation trial. Invest Ophthalmol Vis Sci 2002; E-Abstract 2542.
13. Omenn GS, Goodman GE, Thornquist MD et al. Effects of a combination of beta-carotene and vitamin on lung cancer and cardiovascular disease. N Engl J Med 1994; 330: 1150-5.
14. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35.
15. Jampol LM. AREDS - two years later. Arch Ophthalmol 2003; 121: 1634-6.
16. Wright SE, Keefe JE, Thies LS. Direct cost of blindness in Australia in process citation]. Clin Experiment Ophthalmol 2000; 28: 140-2.
17. Chiang YP, Bassi LJ, Javitt JC. Federal budgetary costs of blindness. Milbank Q 1992; 70: 319-40.
18. Hopley C, Salkeld G, Wang JJ, Mitchell P. Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants. Br J Ophthalmol 2004; 88: 450-4.
19. Wulff M, Ekstrom EC. Iron supplementation during pregnancy in Sweden: To what extent is the national recommendation followed? Acta Obstet Gynecol Scand 2003; 82: 628-35.
20. Nordeng H, Eskild A, Nesheim BI, Aursnes I, Jacobsen G. Guidelines for iron supplementation in pregnancy: Compliance among 431 parous Scandinavian women. Eur J Clin Pharmacol 2003; 59: 163-8.
21. Knudsen VK, Orozova-Bekkevold I, Rasmussen LB, Mikkelsen TB, Michaelsen KF, Olsen SF. Low compliance with recommendations on folic acid use in relation to pregnancy: Is there a need for fortification? Public Health Nutr 2004; 7: 843-50.
22. Turner P, William C. Informed consent: Patients listen and read, but what information do they retain? NZ Med J 2002; 115: U218.
23. Australian Bureau of Statistics. National Regional Profile Census 2001 Australia. Accessed 15 Nov 2004. Available from: http://www.abs.gov.au/ ausstats/abs@.nsf/4b1b45fdcc888128ca256df200817a23/ be7af95b73f5081cca256e5c00192ca9!OpenDocument
24. Australian Bureau of Statistics. National Regional Profile Census 2001, LGA45890 Port Adelaide Enfield (C) (Local Government Area). Accessed 15 Nov 2004. Available from: http://www.abs.gov.au/Ausstats/abs@.nsf/ 4b1b45fdcc888128ca256df200817a23/79cd0faecd26ff8fca256e5c001b2416! OpenDocument
25. Australian Bureau of Statistics. Year Book Australia 2002, Income and Welfare Special Article - Income Support Payments in Australia. Accessed 15 Nov 2004. Available from: http://www.abs.gov.au/Ausstats/abs@.nsf/0/ 780e6ee31ca74ec2ca2569de00221c89?OpenDocument